Form 4 for STRO SUTRO BIOPHARMA, INC.
Accepted 2023-08-11 00:00:00 ET · period of report 2023-08-09 · accession 0001209191-23-045434 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-11 | 2023-08-09 | STRO | Chung Jane | Chief Commercial Off | M - OptEx | $0.00 | +18.8K | 38.2K | +96% | $0 |
| D | 2023-08-11 | 2023-08-09 | STRO | Chung Jane | Chief Commercial Off | F - Tax | $4.22 | -6,483 | 31.7K | -17% | -$27.4K |
| D | 2023-08-11 | 2023-08-09 | STRO | Chung Jane | Chief Commercial Off | M - OptEx | $0.00 | -18.8K | 37.5K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-09 | M | A | 18,750 | $0.00 | 38,181 | D | — | — | |
| 2 | Common | Common Stock | 2023-08-09 | F | D | 6,483 | $4.22 | 31,698 | D | — | — | (F1) Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. |
| 3 | Derivative | Restricted Stock Unit (RSU) | 2023-08-09 | M | D | 18,750 | $0.00 | 37,500 | D | — · — to 2025-08-09 | 18,750 Common Stock | (F2) Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. (F3) The RSUs vest as to 1/4th of the total shares annually beginning on August 9, 2022, subject to the reporting person's provision of service to the issuer on each vesting date. |